CHINA PHARMA HOLDINGS, INC. (CPHI) Form 8-K — Jul 22, 2026
$CPHIForm 8-KItems 1.01, 8.01, 9.01Filed Jul 22, 2026, 5:26 PM ET0001213900-26-080475Original filing
China Pharma Holdings entered into a securities purchase agreement to sell 2,500,000 shares of common stock at $2.00 per share for gross proceeds of $5 million in a registered direct offering. FT Global Capital acted as the exclusive placement agent, earning a 7% cash fee on the proceeds, and net proceeds are designated for working capital purposes.
Key figures
- Gross Proceeds
- 5000000
- Offering Price
- 2
- Shares Offered
- 2500000
- Standstill period days
- 91
- Placement agent fee percent
- 7.0%
- Investor participation right
- 40%
Price after filing
1 day: +8.2%7 days: -29.8%30 days: -38.0%
Close on the filing date to close N calendar days later (from $1.71). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.